TMC207TBC3001 - Early Access of TMC207 in Patients with Extensively Drug Resistant (XDR) or Pre-XDR Pulmonary Tuberculosis (TB)

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021125-12

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to provide early access to TMC207 for subjects who have pulmonary infection due to strains of M. tuberculosis with resistance to INH, RMP, and to a fluoroquinolone (FQ) and/or injectable 2nd line TB drug(kanamycin, amikacin, or capreomycin).


Critère d'inclusion

  • Tuberculosis (TB)

Liens